Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 27, Issue 7, Pages 470-483Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2016.04.014
Keywords
-
Categories
Funding
- Glucocorticoid Induced Osteoporosis Skeletal Endocrinology Group (GIOSEG), University of Brescia, Italy
- Italian Ministry for University and Research (MIUR)
Ask authors/readers for more resources
Diabetes mellitus is a frequent complication of acromegaly, a disease characterized by chronic hypersecretion of growth hormone (GH) by a pituitary adenoma. Diabetes occurs commonly but not only as a consequence of an insulin-resistant state induced by GH excess. The development of diabetes in patients with acromegaly is clinically relevant, since such a complication is thought to increase the already elevated cardiovascular morbidity and mortality risk of the disease. Emerging data suggest that a specific cardiomyopathy can be identified in acromegaly patients with diabetes. Moreover, the presence of diabetes may also influence therapeutic decision making in acromegaly, since traditional and newly developed drugs used in this clinical setting may impact glucose metabolism regardless of control of GH hypersecretion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available